Nang Kuang Pharmaceutical Co., Ltd. (TPE:1752)

Nang Kuang Pharmaceutical Revenue

Nang Kuang Pharmaceutical had revenue of 538.59M TWD in the quarter ending June 30, 2026, a decrease of -0.58%. This brings the company's total for the last twelve months to 2.11B, down -7.50% year-over-year. In the year 2025, Nang Kuang Pharmaceutical had annual revenue of 2.16B, down -1.71%. That makes Nang Kuang Pharmaceutical the 26,007th largest company in the world by revenue and 1,176th in Taiwan.

• Revenue (ttm): 2.11B
• Revenue Growth: -7.50%
• P/S Ratio: 1.44
• Revenue / Employee: 3.82M
• Employees: 552
• Market Cap: 3.04B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• Taiwan 1.70B 78.8%
• Mainland China 209.24M 9.7%
• Japan 101.06M 4.7%
• United States 81.45M 3.8%
• Other Countries 67.60M 3.1%

Fiscal year ended Dec 31, 2025 See the full Nang Kuang Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	2.16B	-37.64M	-1.71%
Dec 31, 2024	2.20B	49.63M	2.31%
Dec 31, 2023	2.15B	209.74M	10.81%
Dec 31, 2022	1.94B	160.39M	9.01%
Dec 31, 2021	1.78B	25.27M	1.44%

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 30, 2026

Data Sources Report a data error